Results 51 to 60 of about 219,023 (115)

A convenient viral transduction based method for advanced multi-engineering of primary human (CAR) T-cells

Journal of Genetic Engineering and Biotechnology
The past decades have illustrated the power of T-cell engineering in the development of new and successful cell therapies, such as chimeric antigen receptor (CAR) T-cells.
Jort J van der Schans, Afroditi Katsarou, George Kladis, Citlali Bar, Max Medina Ramirez, Maria Themeli, Tuna Mutis   +6 more
doaj   +1 more source

Limited Antibodies to Henipaviruses Detected Among Nigerian Horses Using Pseudotyped Virus Neutralization Tests

Viruses
The Hendra virus (HeV; Henipavirus hendraense) and Nipah virus (NiV; Henipavirus nipahense), members of the genus Henipavirus, are high-consequence pathogens that have caused multiple zoonotic outbreaks with high mortality.
Kitty Donnelly, Meshach M. Maina, Ola Elbohy, Olaolu T. Olufemi, Edward Wright, Janet M. Daly   +5 more
doaj   +1 more source

Extra gene coding capacity of SARS-CoV-2 provides a virus engineering platform for in vitro and in vivo applications. [PDF]

Proc Natl Acad Sci U S A
Kim T, Biswas A, Kandel S, Kuroda M, Halfmann PJ, Kawaoka Y.   +5 more
europepmc   +1 more source

A synthetic genomics-based African swine fever virus engineering platform. [PDF]

Sci Adv
Fuchs W, Assad-Garcia N, Abkallo HM, Xue Y, Oldfield LM, Fedorova N, Hübner A, Kabuuka T, Pannhorst K, Höper D, Nene V, Gonzalez-Juarbe N, Steinaa L, Vashee S.   +13 more
europepmc   +1 more source

Amplification of RNA for identification of Zika and HCV in whole blood. [PDF]

Sci Adv
Lim J, Lee H, Wester M, Koprowski K, Van AB, Valera E, Cunningham BT, Bashir R.   +7 more
europepmc   +1 more source

Oncolytic viruses in head and neck cancer: therapeutic promise and translational challenges. [PDF]

Front Immunol
Wang H, Shen H, Zhang M, Mou Y, Ren C, Sun Y, Liu W, Sun C, Li D, Li Y, Qu P, Song X.   +11 more
europepmc   +1 more source

Antigen-presenting nanoparticles for in vivo CAR T cell engineering. [PDF]

Nat Rev Bioeng
Su FI.
europepmc   +1 more source

Overcoming the cytosine base editing barrier: Virus-like particles with uracil-DNA glycosylase inhibition unlocking the clinical potential. [PDF]

Clin Transl Med
Wu Y, Zhu X, Zhu J, Chen J, Hong J.
europepmc   +1 more source

Emerging and Re-Emerging Viral Pathogens in Oncolytic Virotherapy: A Comprehensive Review. [PDF]

Rev Med Virol
An X, Liu N, Liu J.
europepmc   +1 more source

Specific and efficient translation inhibition-transcription activation resistance module against viruses in plants. [PDF]

Sci Adv
Li Z, Zhang J, Yang X, Lu R, He H, Xu Z, Chen Y, Zhou X, Li F.   +8 more
europepmc   +1 more source